Recent studies suggest that IGF1 analogs or IGF2 could help alleviate social and behavioral deficits in autism (Neul et al., 2022; Pizzarelli et al., 2023), indicating a potential link between IGF signaling disruptions and autism. The gene discussed is IGF1; the disease is autism.